Pages that link to "Q26774355"
Jump to navigation
Jump to search
The following pages link to Tumor resistance to vascular disrupting agents: mechanisms, imaging, and solutions (Q26774355):
Displaying 12 items.
- Pericyte-targeting prodrug overcomes tumor resistance to vascular disrupting agents. (Q38941996) (← links)
- Tumor vascular infarction: prospects and challenges (Q39065317) (← links)
- Anti-angiogenic agents for the treatment of solid tumors: Potential pathways, therapy and current strategies - A review. (Q41258130) (← links)
- Radioimmunotherapy for CD133(+) colonic cancer stem cells inhibits tumor development in nude mice (Q41279707) (← links)
- The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells (Q49302678) (← links)
- Monitoring tumor response to the vascular disrupting agent CKD-516 in a rabbit VX2 intramuscular tumor model using PET/MRI: Simultaneous evaluation of vascular and metabolic parameters (Q50041830) (← links)
- Synthesis of dihydronaphthalene analogues inspired by combretastatin A-4 and their biological evaluation as anticancer agents (Q57574255) (← links)
- Enhanced Photothermal Treatment Efficacy and Normal Tissue Protection via Vascular Targeted Gold Nanocages (Q64063060) (← links)
- Photochemically-Induced Release of Lysosomal Sequestered Sunitinib: Obstacles for Therapeutic Efficacy (Q89697167) (← links)
- Potential Therapeutic Strategies for Lung and Breast Cancers through Understanding the Anti-Angiogenesis Resistance Mechanisms (Q92734088) (← links)
- The influence of hypoxia and energy depletion on the response of endothelial cells to the vascular disrupting agent combretastatin A-4-phosphate (Q96576569) (← links)
- Wikidata:Database reports/Constraint violations/P275 (← links | edit)